news aktuell GmbHnews aktuell GmbH

Xella successfully completes sale of URSA

1.6.2022 14:29:48 CEST | news aktuell GmbH | Press release

Share
Sale of insulation business is an important step to focus on building materials solutions Xella is ideally positioned in a rapidly changing industry

Duisburg, June 1st, 2022 – Xella Group, a leading European building materials provider of sustainable, efficient, and affordable walling solutions, today announced that it has successfully completed the sale of its insulation business URSA to Etex. The transaction closed today with the approval of relevant authorities and includes 13 production sites. URSA is a European leader in extruded polystyrene (XPS) and featuring among the top three producers for glass mineral wool. Financial details of the transaction were not disclosed.

Christophe Clemente, CEO of Xella, comments: “With this portfolio simplification, Xella makes an important step to focus its resources on the development of building materials solutions. With our complementary product types, autoclaved aerated concrete and calcium silicate products, we aim to strengthen our position as a leading European supplier of masonry solutions. I warmly thank the URSA teams for their achievements during the successful past years within Xella Group and wish them a bright future with Etex.”

Bernard Delvaux, CEO of Etex, adds: “With the acquisition of URSA we continue to become a global leader in lightweight and modular construction. This acquisition is a perfect fit for Etex, combining a new growth platform with a strong focus on sustainability. I warmly welcome more than 1,700 URSA employees and look forward to continuing the success story together.”

Over the past few years, Xella developed from a pure manufacturer of building and insulation materials into a customer-oriented solution provider for the entire building envelope. The company strives to provide energy-efficient, sustainable, and cost efficient residential and commercial buildings solutions. This positions Xella to serve a rapidly changing industry, which is increasingly characterized by the demand for efficient, less labor intensive and sustainable construction.

About Xella Group

The Xella Group is a European provider of efficient and sustainable walling solutions for the entire house shell. Xella is home of well-known brands such as Ytong, Silka, Hebel and Multipor and a pioneer in digitally supported construction processes. Our high-performing products based on natural raw materials address the need for efficient construction and the demand for sustainable building solutions. The group drives innovation along the entire value chain from planning to production and installation. Xella improves the sustainability of buildings throughout their entire lifecycle and contributes to a low carbon industry compatible with a circular economy. Headquartered in Duisburg, Germany, the Xella Group excluding URSA generated, with more than 5,300 employees, sales of around € 1.2 billion in 2021.

For more information on Xella Group, visit: www.xella.com

Contacts

Images

About news aktuell GmbH

news aktuell GmbH
news aktuell GmbH
Mittelweg 144
20148 Hamburg

+49 (0)40 4113-32589http://www.newsaktuell.de

news aktuell, a subsidiary of the Deutsche Presse-Agentur (dpa), provides companies, institutions and associations with effective access to both the media and consumers and supports the organizations in telling their stories easily and successfully. Utilizing the digital tools “ots” and “zimpel” PR content reaches all media formats, including classic print titles, wide-reach online portals or social networks. In addition, news aktuell publishes all of its clients' PR content on www.presseportal.de, one of Germany's widest-reaching PR portals. Thus, all relevant multipliers are reached worldwide, ranging from editors and digital influencers to specialist bloggers and interested consumers. Communications specialists from all over Germany rely on the expertise of the dpa subsidiary. news aktuell has been on the market since 1989 and employs over 135 people. The company is based in Hamburg. Further locations include Berlin, Frankfurt and Munich.

Subscribe to releases from news aktuell GmbH

Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from news aktuell GmbH

Vyoma awarded ESA data procurement contract for space-based data on small space debris24.2.2026 10:53:34 CET | Press release

(Munich, February 24th, 2026) Vyoma, a Munich-based company providing Space Domain Awareness (SDA) capabilities, has been selected as the winner of the ESA tender on ”Data Procurement for Space-Based Statistical Data on Small Space Debris Phase 1”, funded via ESA‘s Space Safety Programme (S2P). ESA’s Meteoroid And Space debris Terrestrial Environment Reference (MASTER) model provides a description of the space environment around Earth, supporting satellite designers, operators and others with risk assessments. Currently, there exists a significant temporal and spatial knowledge gap for observations of space debris with sizes smaller than the detection limit of ground-based sensors. Vyoma's Flamingo-1 satellite is ideally positioned to generate the image data ESA is seeking. Flying “in-situ” at an altitude of 510 km, Flamingo-1's instrument can monitor large volumes of space at once. This sensor detects objects at long and short distances and captures small and fast objects reliably, im

Medi-Globe Launches mAI Companion® — the World’s First Real Time AI Assistant for Pancreatic EUS, Co Developed with IHU Strasbourg —Now MDR CE Marked and Available for Clinical Use in Europe24.2.2026 10:00:00 CET | Press release

Rohrdorf (Achenmühle), Germany — February 24, 2026 — Medi-Globe today announced the launch of mAI Companion®, a real-time medical AI solution designed to assist physicians in detecting pancreatic lesions during endoscopic ultrasound (EUS) — addressing one of the deadliest and most difficult-to-detect cancers, where earlier identification can dramatically change patient outcomes.

Grünenthal licenses exclusive Australian rights to Qutenza® to Clinect24.2.2026 08:43:52 CET | Press release

Aachen, Germany & Victoria, Australia, 24 February 2026 – Grünenthal, a global leader in pain management and related diseases, and Clinect Pty Ltd ("Clinect"), an Australian based company focussed on supporting access to unique products, announced today that they have entered into a definitive agreement whereby Clinect will have the exclusive Australian rights to Qutenza®, a topical, non-systemic, non-opioid patch indicated for the management of peripheral neuropathic pain. Under the agreement, Clinect will be responsible for obtaining marketing authorisation for Qutenza® in Australia and, upon approval, marketing and distributing the product in Australia.

Clean energy needs a clean planet: PLAN-B NET ZERO and everwave launch joint initiative20.2.2026 13:26:02 CET | Press release

(Berlin, Germany) A strong start to 2026. PLAN-B NET ZERO enters into a partnership with the Aachen-based environmental scale-up everwave. With the guiding principle ‘1 euro = 1 kilogram of waste’, the partners recovered 10,000 kilograms of waste from rivers in Cambodia at the start of the initiative Around 11 million tonnes of plastic waste enter the oceans every year. Without effective countermeasures, this volume could almost triple by 2040. Studies show that about 80 percent of marine plastic reaches the sea via roughly 1,656 rivers worldwide. To date, everwave has removed more than 2.4 million kilograms of plastic from rivers in Cambodia, Albania, and Thailand. The company uses waste collection boats, barriers, and manual cleanups to stop plastic before it reaches the oceans. At the same time, mobile sorting and recycling solutions return materials efficiently to the circular economy. AI support optimizes collection routes to clean as many waterways as possible in a sustainable wa

Grünenthal’s proprietary NaV 1.8 inhibitor enters clinical development18.2.2026 11:52:51 CET | Press release

Aachen, Germany, 18 February 2026 – Grünenthal announced today that the first healthy volunteers have been enrolled in a Phase I trial of its voltage-gated sodium channel (NaV) 1.8 inhibitor. The orally administered investigational medicine aims to provide a non-opioid therapy option across a range of acute and chronic pain conditions. Full results of the trial are expected in the second half of 2026.

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye